F2R and acute coronary syndrome: Additionally, based on the results of the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) experiment, increased attention has been paid to preventing bleeding complications in patients using DAPT.